'Dyslipidemia drugs market involves' presentation slideshows

Dyslipidemia Drugs Market Research Report Forecast to 2023

According to the research report, the global dyslipidemia market is anticipated to witness a decline of -10.3%. CAGR between 2015 and 2023. The negative growth rate is a result of the expiration of blockbuster drugs that have allowed the introduction of several generic drugs, available at cheaper prices than branded drugs. Owing to this reason, the global market is expected to reach a valuation of US$6.88 bn by 2023 as compared to US$17.85 bn in 2014.

60 views • 3 slides